Type 1 diabetes (T1D) is a life-long condition where the immune system destroys part of the body called the pancreas which makes insulin. The body needs insulin to control blood sugar levels. Treatment involves replacing the body’s insulin over one’s lifetime using injections or an insulin pump.
The risk of developing T1D increases when people have markers in their blood called T1D (or islet) antibodies. Children with 2 or more T1D antibodies have an 80-90% chance of developing T1D within 15 years, and nearly all of these children will develop T1D in their lifetime. Children with only 1 of these markers have a lower risk (15%) of developing T1D within 15 years. In adults, less is understood about the natural history of being antibody positive, and we hope this study will help us understand more.
We have developed a registry of children and adults with T1D antibodies to:
Story (coming soon)
Story (coming soon)
Research studies in the UK offering screening for type 1 (islet) autoantibodies now or in the past include:
Have you (or your child) been tested for type 1 (islet) autoantibodies as part of a research study? If so, you are eligible to join the Registry
If your (or your child’s) blood has been tested by a doctor (eg by your GP or in the hospital) and shown to have one or more type 1 (islet) autoantibodies, check your eligibility to join the registry.
If you are not sure, and you want to talk to someone...
